Scientists in the United States and other countries published papers saying that hydroxychloroquine treatment of the new crown will lead to increased deaths
Four scientists from the United States, including Mandeep R. Mehra, published a paper in the international medical journal "The Lancet" on the 22nd, saying that for more than 9,600 hospitals in the world due to new coronavirus infections The analysis of the treatment of the patients found that the use of hydroxychloroquine or chloroquine (with or without macrolides) treatment program is not beneficial to the treatment of patients with new coronavirus infection, on the contrary, it will increase ventricular arrhythmia and hospital deaths danger. These findings indicate that these drugs should not be used outside of clinical trials and require urgent confirmation from randomized clinical trials.
The paper is based on the results of a controlled analysis of 14,888 patients who received hydroxychloroquine, chloroquine, or simultaneous use of macrolides in various regions of the world, and 81144 other patients who did not receive these drugs. The paper stated that it was not possible to prove that the use of hydroxychloroquine or chloroquine alone or with macrolides is beneficial for the treatment of new coronavirus infections; however, when used to treat patients with new crowns, each of these drug regimens is associated with a reduction in hospital survival It is related to the increased frequency of ventricular arrhythmias.
Earlier, after the French doctor Didier Raoult had cured the patient at the Latimone hospital in Marseille, he claimed to have used hydroxychloroquine for treatment. Subsequently, US President Trump claimed that hydroxychloroquine, a drug used to treat malaria, is a drug that can treat new coronavirus infections, saying that he will use it for anti-new coronavirus treatment. (Taiwan reporter Tian Xiaochun)